Discontinued Operations The summary of the assets and liabilities related to Pharmaceutical Manufacturing- China discontinued operations (Details) (USD $)				3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012	Jun. 30, 2012 Pharmaceutical Manufacturing - China business [Member]	Jun. 30, 2012 Pharmaceutical Manufacturing - China business [Member]	Dec. 31, 2012 Pharmaceutical Manufacturing - China business [Member]	Nov. 13, 2012 Pharmaceutical Manufacturing - China business [Member]	Dec. 31, 2012 Equity Purchase Agreement [Member] CBH Acquisition LLC [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Accrued Liabilities						$ (2,008,800)
Equity Method Investment, Ownership Percentage								51.00%
Available-for-sale Securities, Fair Value Disclosure						13,397,900
Noncontrolling interests	(471,006)	(356,970)				6,015,000
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax						4,387,400
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	0		16,149,188			8,457,500
Cash and cash equivalents	14,722,478	13,737,452	2,112,582				12,300,000
Restricted cash						2,918,100
Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net						6,130,200
Inventory						15,077,700
Prepaid expenses and other current assets						957,800
Property, plant and equipment, net						38,102,000
Other assets						5,946,300
Disposal Group, Including Discontinued Operation, Accounts Payable						9,604,800
Total assets		23,800,300
Bank loans						(15,133,500)
Notes payable						(6,599,300)
Unearned revenue						(9,166,800)
Amount due related parties						(7,859,700)
Total Liabilities						(27,216,700)
Loss on exit of segment				$ 0	$ 0	$ (3,416,400)
Treasury Stock, Shares							104,000
Stock Option Cancelled							117,000
Warrants Cancelled							64,000